RMTC Issues Drug Bulletins on Purple Pain and TB-500 7/2/13

NEWS RELEASE July 2, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC ISSUES DRUG BULLETINS ON PURPLE PAIN AND TB-500 The Racing Medication and Testing Consortium (RMTC) Tactical Research Committee has reviewed data from laboratory analysis of two substances of concern in racing that have been marketed as powerfully effective drugs – “Purple Pain” and

RMTC Board Recommends Therapeutic Withdrawal Times, Grants First Interim Lab Accreditation 3/21/13

NEWS RELEASE March 21, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD RECOMMENDS THERAPEUTIC WITHDRAWAL TIMES, GRANTS FIRST INTERIM LAB ACCREDITATION At its March 19 meeting in Baltimore, Maryland, the Racing Medication and Testing Consortium (RMTC) board of directors adopted recommendations for thresholds and withdrawal times for four therapeutic medications identified by the Association

Statement from the Racing Medication and Testing Consortium 8/30/12

NEWS RELEASE August 30, 2012 Contact: Hallie Lewis (859) 224-2848 STATEMENT FROM THE RACING MEDICATION AND TESTING CONSORTIUM The Kentucky Horse Racing Commission recently approved regulations based on the Association of Racing Commissioners International (RCI) Model Rules. The regulations concern major medications reported to the public in racing forms. These model rules, which incorporated broad

RMTC Board Will Meet Next Week in Austin, Texas 3/20/08

NEWS RELEASE March 20, 2008 RMTC BOARD WILL MEET NEXT WEEK IN AUSTIN, TEXAS On Tuesday, March 25, the board of directors of the Racing Medication and Testing Consortium (RMTC) will meet at the Driskell Hotel in Austin, Texas, for their spring board meeting. The RMTC will hear reports from four of its committees, including